dspaceThe Cape Peninsula University of Technology (CPUT) Electronic Theses and Dissertations (ETD) repository holds full-text theses and dissertations submitted for higher degrees at the University (including submissions from former Cape Technikon and Peninsula Technikon).

Show simple item record

dc.contributor.advisorTruter, E. J.
dc.contributor.advisorBohm, E. L. J. F.
dc.contributor.authorSerafin, Antonio Mendes
dc.date.accessioned2016-06-13T08:27:51Z
dc.date.accessioned2016-09-15T09:28:57Z
dc.date.available2016-06-13T08:27:51Z
dc.date.available2016-09-15T09:28:57Z
dc.date.issued2000
dc.identifier.urihttp://hdl.handle.net/20.500.11838/2245
dc.descriptionThesis (MTech (Biomedical Technology))--Cape Technikon, 2011.en_US
dc.description.abstractCancer of the prostate gland is now recognised as one of the principal medical problems in males. In the USA, cancer of the prostate is the second most commonly diagnosed cancer after skin cancer and the second most common cause of death from cancer after lung cancer. In South Africa, prostate cancer is the second most common cancer, with an estimated annual incidence of 19.1 per LOO000 men (Sitas, 1994). However, this incidence is probably under-estimated, due to incomplete records. Comparison of the incidence of prostate cancer in the different racial groups shows that it is the second most common malignancy in the White, Black (African) and Mixed (Coloured) race groups, and the fourth most common malignancy in Asian (Indian) men in South Africa. Metastatic prostate cancer is refractory to hormone therapy and remains incurable. Hence, novel therapeutic approaches are needed. These anticancer drugs can be tested in tumour cell lines, and cell culture methods also permit testing of optimum conditions.en_US
dc.language.isoenen_US
dc.publisherCape Technikonen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/za/en
dc.subjectProstate -- Cancer -- Treatmenten_US
dc.subjectCell linesen_US
dc.subjectChemotherapyen_US
dc.subjectApoptosisen_US
dc.titleChemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogationen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/3.0/za/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/3.0/za/